- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 524.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 526M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 526M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $237M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $225M |
| Capex | Q1 2026 · Mar 31, 2026 | $624M |
| Capex | Q1 2026 · Mar 31, 2025 | $477M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $204M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $235M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $980M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $346M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $674M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $892M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $18.06B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $18.33B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.31B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.06B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $27.09B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $26.8B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $10.55B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $10.44B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $45.17B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $45.16B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.12 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.73 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.74 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $961M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $973M |
| Net Income | Q1 2026 · Mar 31, 2026 | $65M |
| Net Income | Q1 2026 · Mar 31, 2025 | $384M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $253M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $553M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.27B |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $1.58B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $6.44B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $6.08B |
| Revenue | Q1 2026 · Mar 31, 2026 | $7.71B |
| Revenue | Q1 2026 · Mar 31, 2025 | $7.66B |